BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22489701)

  • 1. Tumor-specific histone signature and DNA methylation in multiple myeloma and leukemia cells.
    Foltankova V; Legartova S; Kozubek S; Bartova E
    Neoplasma; 2012; 59(4):450-62. PubMed ID: 22489701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of epigenetic-based anti-cancer drugs in leukaemia and multiple myeloma cells.
    Jugová A; Sustáčková G; Legartová S; Stixová L; Kozubek S; Bártová E
    Cell Biol Int; 2011 Dec; 35(12):1195-203. PubMed ID: 21635225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of multiple myeloma after treatment with cytostatics and gamma radiation.
    Krejcí J; Harnicarová A; Streitová D; Hájek R; Pour L; Kozubek S; Bártová E
    Leuk Res; 2009 Nov; 33(11):1490-8. PubMed ID: 19362368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
    Krieger S; Grunau C; Sabbah M; Sola B
    Exp Hematol; 2005 Jun; 33(6):652-9. PubMed ID: 15911089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
    Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
    Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic aspects of HP1 exchange kinetics in apoptotic chromatin.
    Legartová S; Jugová A; Stixová L; Kozubek S; Fojtová M; Zdráhal Z; Lochmanová G; Bártová E
    Biochimie; 2013 Feb; 95(2):167-79. PubMed ID: 23023195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
    Kusumoto T; Hamada T; Yamada N; Nagata S; Kanmura Y; Houjou I; Kamikawa Y; Yonezawa S; Sugihara K
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1486-94. PubMed ID: 21821326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
    Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC
    J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of CIITA expression in human T-cells.
    van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
    Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia.
    Rahat B; Hamid A; Ahmad Najar R; Bagga R; Kaur J
    Mol Hum Reprod; 2014 Oct; 20(10):1026-40. PubMed ID: 25024139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata.
    Zhao M; Liang G; Wu X; Wang S; Zhang P; Su Y; Yin H; Tan Y; Zhang J; Lu Q
    Br J Dermatol; 2012 Feb; 166(2):226-73. PubMed ID: 21936853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylation directs DNA methylation in survivin gene silencing.
    Ma AN; Lu J; Zhou XJ; Wang YX
    Biochem Biophys Res Commun; 2011 Jan; 404(1):268-72. PubMed ID: 21130077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
    Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.